USE OF SALIVA IN-HOME MONITORING OF CARBAMAZEPINE LEVELS

被引:29
作者
ROSENTHAL, E
HOFFER, E
BENARYEH, H
BADARNI, S
BENDERLY, A
HEMLI, Y
机构
[1] RAMBAM MED CTR, ISRAEL POISON INFORMAT CTR, IL-31096 HAIFA, ISRAEL
[2] RAMBAM MED CTR, DEPT ORAL & MAXILLOFACIAL SURG, ORAL BIOL LAB, IL-31096 HAIFA, ISRAEL
[3] RAMBAM MED CTR, DEPT NEUROL, IL-31096 HAIFA, ISRAEL
[4] TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, IL-31096 HAIFA, ISRAEL
关键词
EPILEPSY; CARBAMAZEPINE; SALIVARY DRUG LEVELS; SERUM DRUG LEVELS; HOME MONITORING;
D O I
10.1111/j.1528-1157.1995.tb01668.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Total carbamazepine (CBZ) levels in serum of 61 epileptic children were compared with saliva levels. Both resting and stimulated saliva was analyzed. The salivary levels were 38.6% of serum CBZ levers. A highly significant correlation was noted (r = 0.89, p < 0.001). Stimulation had no effect on saliva CBZ levels (r = 0.97). Salivary and serum CBZ levels were not affected by storing the samples for 7 days at room temperature. The data indicate that salivary CBZ may provide a reliable alternative monitoring method to Tegretol therapy, especially in children, in whom blood sampling is difficult. Furthermore, the samples may be collected at home and delivered to the laboratory by mail.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 17 条
[1]   USE OF SALIVA IN MONITORING CARBAMAZEPINE MEDICATION IN EPILEPTIC CHILDREN [J].
BARTELS, H ;
OLDIGS, HD ;
GUNTHER, E .
EUROPEAN JOURNAL OF PEDIATRICS, 1977, 126 (1-2) :37-44
[2]   THE SALIVARY FLOW-RATE AND COMPOSITION OF WHOLE AND PAROTID RESTING AND STIMULATED SALIVA IN YOUNG AND OLD HEALTHY-SUBJECTS [J].
BENARYEH, H ;
SHALEV, A ;
SZARGEL, R ;
LAOR, A ;
LAUFER, D ;
GUTMAN, D .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1986, 36 (02) :260-265
[3]  
BUCHANAN N, 1986, AUST PAEDIATR J, V22, P19
[4]  
CHAMBERS RE, 1977, LANCET, V1, P656
[5]   DIURNAL-VARIATION OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN PLASMA AND SALIVA IN CHILDREN WITH EPILEPSY - A COMPARISON BETWEEN CONVENTIONAL AND SLOW-RELEASE FORMULATIONS [J].
EEGOLOFSSON, O ;
NILSSON, HL ;
TONNBY, B ;
ARVIDSSON, J ;
GRAHN, PA ;
GYLJE, H ;
LARSSON, C ;
NOREN, L .
JOURNAL OF CHILD NEUROLOGY, 1990, 5 (02) :159-165
[6]   UTILITY OF FREE LEVEL MONITORING OF ANTIEPILEPTIC DRUGS [J].
LEVY, RH ;
SCHMIDT, D .
EPILEPSIA, 1985, 26 (03) :199-205
[7]   SALIVARY CONCENTRATIONS AND PLASMA-PROTEIN BINDING OF CARBAMAZEPINE AND CARBAMAZEPINE 10,11-EPOXIDE IN EPILEPTIC PATIENTS [J].
MACKICHAN, JJ ;
DUFFNER, PK ;
COHEN, ME .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (01) :31-37
[8]   INTRAINDIVIDUAL VARIABILITY OF CARBAMAZEPINE, PHENOBARBITAL, AND PHENYTOIN CONCENTRATIONS IN SALIVA [J].
MILES, MV ;
TENNISON, MB ;
GREENWOOD, RS .
THERAPEUTIC DRUG MONITORING, 1991, 13 (02) :166-171
[9]   EVALUATION OF THE AMES SERALYZER FOR THE DETERMINATION OF CARBAMAZEPINE, PHENOBARBITAL, AND PHENYTOIN CONCENTRATIONS IN SALIVA [J].
MILES, MV ;
TENNISON, MB ;
GREENWOOD, RS ;
BENOIT, SE ;
THORN, MD ;
MESSENHEIMER, JA ;
EHLE, AL .
THERAPEUTIC DRUG MONITORING, 1990, 12 (05) :501-510
[10]   CONCENTRATIONS AND KINETICS OF CARBAMAZEPINE IN WHOLE SALIVA, PAROTID-SALIVA, SERUM ULTRA-FILTRATE, AND SERUM [J].
PAXTON, JW ;
DONALD, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) :695-702